PharmEasy
E-pharmacy/healthtechIndia
βοΈ Markdown
PeakΒ $5.6 BillionToday
~-92%
from peak
- π¦Became a unicornApr 2021
- πPeak valuation$5.6 Billion β21
- πBecame a Unitard~2023
- πΈLast valuation~$448M
Current status
Marked to ~$456M (Dec 2024)
How it happened
PharmEasy is an Indian online pharmacy and healthtech platform that peaked at roughly $5.6B in 2021 after rapid pandemic-era growth and acquisitions. Mounting losses and debt forced a heavily discounted rights issue and steep markdowns by investors. Neuberger Berman marked its stake down to imply a valuation near $456M by late 2024, a fall of about 92% from peak.
Source: Inc42